Connect with us

Headlines

J&J Splits Into 2 Organizations

Its pharmaceutical and medical device business will stand alone, as will consumer products.

mm

Published

on

Johnson & Johnson (New Brunswick, N.J.) will separate its pharmaceutical and medical device business from its consumer products division, reports Quartz. The split is expected to be completed in two years.

While the consumer products business will be part of a newly named, publicly traded company, the pharma/medical device business will remain under the J&J banner. The prescription drug and medical device divisions are the brand owner’s fastest-growing and most profitable businesses. Consumer products, on the other hand is slower-growing and is also facing numerous lawsuits regarding its talc products.

Since launching in 2014, INVISION has won 23 international journalism awards for its publication and website. Contact INVISION's editors at [email protected].

SPONSORED VIDEO

Shamir Glacier Plus Metaform: Stronger. Thinner. Lighter.

It’s time for a new compromise-free lens technology that completely changes our concept of what’s possible. Glacier Plus™ Metaform enables customers to enjoy strength and safety alongside the aesthetics of thin and light lenses. Coming Soon: The next technical revolution in the world of optics.

Promoted Headlines

Advertisement

Advertisement

Subscribe

INVISIONMAG.COM
BULLETINS

Get the most important news and business ideas for eyecare professionals every weekday from INVISION.

Advertisement

Most Popular